04:32 PM EST, 12/08/2025 (MT Newswires) -- Assembly Biosciences ( ASMB ) said Monday interim Phase 1b results showed its weekly oral candidate ABI-1179 cut HSV-2 shedding by 98% and virologically confirmed genital lesion rates 91% versus placebo. The company said its monthly oral ABI-5366 regimen reduced Herpes Simplex Virus-2 shedding by 76% and virologically confirmed lesion rates by 88%....

04:33 PM EST, 12/08/2025 (MT Newswires) -- Philip McCabe, Executive Vice President and Head of SEI's Investment Management Business, on December 04, 2025, sold 12,000 shares in Sei Investments ( SEIC ) for $973,320. Following the Form 4 filing with the SEC, McCabe has control over a total of 64,986 common shares of the company, with 62,544 shares held directly...

04:32 PM EST, 12/08/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) commenced an underwritten public offering of $300 million of common stock. Underwriters have a 30-day option to buy up to an additional $45 million in shares, the company said Monday in a statement. Dyne shares fell 5.4% in after-hours trading. ...

04:34 PM EST, 12/08/2025 (MT Newswires) -- Protara Therapeutics ( TARA ) said late Monday it has closed an underwritten public offering of about 13 million shares at $5.75 per share, for gross proceeds of roughly $75 million. Underwriters were given a 30-day option to buy up to about 1.96 million additional shares, the company said. Net proceeds will be...